by Maria Zannes | Feb 11, 2021 | News
FEBRUARY 8, 2021 As published in the San Antonio Business Journal By: W. Scott Bailey – Senior Reporter, San-Antonio Business Journal “China represents a $5 billion market for CyPath© Lung. An estimated 780,000 people will be diagnosed annually in China with lung...
by Maria Zannes | Feb 5, 2021 | Events
Dr. David Elzi will present his poster “Simultaneous knockdown of CD320 and LRP2 receptors is selectively toxic to cancer cells but not normal cells” at the American Association of Cancer Research (AACR) Virtual Annual Meeting 2021, April 10-15 and May 17-21. Session:...
by Maria Zannes | Feb 4, 2021 | Press Releases
FEBRUARY 4, 2021 (SAN ANTONIO, TX) China’s leading healthcare company to evaluate bioAffinity’s non-invasive, highly accurate test for early-stage lung cancer with aim to commercialize in world’s largest market Shanghai Fosun Long March Medical Science Co., Ltd....
by Maria Zannes | Jan 27, 2021 | Events
Chief Medical & Science Officer Vivienne Rebel, MD, PhD, will present her poster “Automated Flow Cytometry Test Distinguishes Cancer from Non-Cancer in Sputum with High Sensitivity and Specificity” on January 28th through January 31st, 2021, at the International...
by Maria Zannes | Jan 27, 2021 | Articles
JANUARY 19, 2021 Contributed Commentary by Maria Zannes When it comes to cancer, there are many tools for cancer diagnosis, from initial screenings to invasive biopsies. The one selected depends on a number of factors, not the least of which is how the patient...
